0

5-(4-Phenoxybutoxy)psoralen

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP870653455
CAS870653-45-5
MDL NumberMFCD11114059
Molecular Weight350.36
InChI KeyKINMYBBFQRSVLL-UHFFFAOYSA-N
Description≥98% (HPLC), solid
SolubilityDMSO: 9 mg/mL
Assay≥98% (HPLC)
Colorwhite
Formsolid
Size5MG, 25MG
Storage Conditions2-8°C
1

4-Phenoxybutoxy-substituted Heterocycles--A Structure-Activity Relationship Study of Blockers of the Lymphocyte Potassium Channel Kv1.3

Silke B Bodendiek, Cédrick Mahieux, Wolfram Hänsel, Heike Wulff

Eur J Med Chem. 2009 May;44(5):1838-52.

PMID: 19056148

1

Identification of phase-I Metabolites and Chronic Toxicity Study of the Kv1.3 Blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the Rat

B Hao, Z-W Chen, X-J Zhou, P I Zimin, G P Miljanich, H Wulff, Y-X Wang

Xenobiotica. 2011 Mar;41(3):198-211.

PMID: 21070145

1

Inhibition of Voltage-Gated K + Channel Kv1.5 by Antiarrhythmic Drugs

Rong Chen, Shin-Ho Chung

Biochemistry. 2018 May 8;57(18):2704-2710.

PMID: 29652491

1

Pharmacokinetics, Toxicity, and Functional Studies of the Selective Kv1.3 Channel Blocker 5-(4-phenoxybutoxy)psoralen in Rhesus Macaques

L E Pereira, F Villinger, H Wulff, A Sankaranarayanan, G Raman, A A Ansari

Exp Biol Med (Maywood). 2007 Nov;232(10):1338-54.

PMID: 17959847

1

Stimulation of Glucose Uptake in Murine Soleus Muscle and Adipocytes by 5-(4-phenoxybutoxy)psoralen (PAP-1) May Be Mediated by Kv1.5 Rather Than Kv1.3

Robert A Ngala, Mohamed S Zaibi, Kenneth Langlands, Claire J Stocker, Jonathan R S Arch, Michael A Cawthorne

PeerJ. 2014 Oct 7;2:e614.

PMID: 25320682

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode